cablivi - caplacizumab(Caplacizumab)Medication DetailsGenzyme CorporationUsage: Cablivi treats acquired thrombotic thrombocytopenic purpura (aTTP) in adults and pediatric patients 12 and older, used alongside plasma exchange and immunosuppressive therapy.Medication Details